Therapeutic properties of isoliquiritigenin with molecular modeling studies: investigation of anti-pancreatic acinar cell tumor and HMG-CoA reductase inhibitor activity for treatment of hypercholesterolemia.

Authors:
Li J; Zhu F; Xu W; Che P.

Journal:
Arch Med Sci

Publication Year: 2022

DOI:
10.5114/aoms/145448

PMCID:
PMC10696990

PMID:
38058725

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: Arch Med Sci

Detailed journal information not available.

Publication Details

Subject Category: Medicine, General & Internal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025